Cannabis and Controlled Substances Group

The firm’s multi-disciplinary Cannabis and Controlled Substances group has extensive experience in handling the rulemaking, regulatory, transactional, legislative, and litigation aspects of Florida’s regulated industries. With billion dollar industries such as medical cannabis burgeoning in the state of Florida, the Cannabis and Controlled Substances group can provide the support and guidance necessary to successfully navigate regulatory complexities. Our attorneys advise companies, individuals and investors on a wide range of legal and public policy issues surrounding Florida’s medical cannabis industry. Those businesses directly involved in the cultivation, processing, distribution, and dispensing of medical cannabis are not the only industries impacted by medical cannabis’ dynamic regulatory framework. Issues surrounding corporate formation, investments, permitting, environmental compliance, privacy and technology, employment contracts and policies, commercial and medical office leasing, real estate transactions, regulatory compliance, and land use and zoning must all be carefully analyzed to ensure businesses anticipate and prepare for the impacts of medical cannabis regulations. Our experience encompasses areas critical to the success of our clients in a variety of fields impacted by Florida’s regulated industries.

For questions or more information, please contact Tim Miedona, Chair, and Tara Tedrow, Co-Chair of the firm's Cannabis and Controlled Substances Group.

DISCLAIMER: Notwithstanding state marijuana laws that may exempt individuals and entities from state criminal prosecution, parties may remain subject to federal criminal prosecution as marijuana remains a Schedule I drug under federal law.